Payment & Reimbursement

This is a way for clinicians to bill for a group of services in the office setting similar to the services covered under the Opioid Treatment Program (OTP) benefit for clinics.

This whitepaper examines telehealth risks utilizing the eight American Society for Health Care Risk Management (ASHRM) enterprise risk management (ERM) domains.

This guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. Approaches presented will assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders, including alcohol.

This brief explores COVID-19 policy changes related to access to medications for opioid use disorder and recommends changes to keep in place beyond the emergency period.

Includes three training modules and a final exam for licensed SBIRT providers in Wisconsin to become eligible for Medicaid reimbursement for SBIRT services

Examines the association between providing SBIRT and healthcare costs, demonstrating that SBIRT was associated with a savings of $391 per Medicaid beneficiary

Provides information on Medicare, Medicaid, and commercial reinsurance reimbursement for SBIRT in Wisconsin

Describes the updates made in 2019 to the SBIRT Coding & Reimbursement Guide

Report to Congress describing different options for medication-assisted treatment (MAT) for substance use disorders, Federal and State policies outlining Medicaid coverage for MAT across the United States, and summarizing utilization of MAT among Medicaid beneficiaries

Identifies four steps that will help to ensure that a broader transition to telehealth will be successful in improving the health outcomes of patients with substance use disorders